文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

成人重症监护中中心血管通路装置的并发症与失败

Complication and Failures of Central Vascular Access Device in Adult Critical Care Settings.
PubMed 文献 · Crit Care Med · 2018-01-01
一句话结论成人ICU中中心静脉通路装置失败率5%,疑似感染导致拔管比例高达17%,而导管相关血流感染率总体较低,提示需规范拔管决策。

该研究系统检索截至2017年9月的文献,纳入63项观察性或干预性研究,共50,000根中心静脉通路装置、396,951个导管日,评估成人ICU中装置失败与并发症的比例和发生率。结果显示装置失败率为5%(95%CI 3-6%),血液透析导管失败率最高;总体中心线相关血流感染率为4.59/1000导管日(95%CI 2.31-6.86),非隧道式装置最高;因疑似感染拔管比例达17%(20.4/1000导管日,95%CI 15.7-25.2)。作者认为尽管总体感染率低,高疑似感染拔管比例提示需制定稳健的实践指南来指导拔管决策。

要点

  • 成人ICU中中心静脉通路装置失败率为5%(95%CI 3-6%),血液透析导管的失败率和比例最高。
  • 总体中心线相关血流感染率为4.59/1000导管日(95%CI 2.31-6.86),非隧道式中心静脉装置发生率最高。
  • 因疑似感染拔除中心静脉装置的比例高达17%(20.4/1000导管日,95%CI 15.7-25.2)。
  • 作者认为总体中心线相关血流感染和导管相关血流感染率低而疑似感染拔管比例高,提示需稳健的实践指南指导疑似感染装置的拔除决策。

适用人群与场景

  • 成人ICU中留置中心静脉通路装置的患者,纳入观察性(前瞻性或回顾性)或干预性设计的研究。
  • 排除2006年11月前发表或非英文报告的研究。

研究设计与关键结果

  • 系统检索Cochrane Central Register of Controlled Trials、Embase、U.S. National Library of Medicine National Institutes of Health和Cumulative Index to Nursing and Allied Health,检索时间为2017年9月。
  • 共纳入63项研究,涉及50,000根中心静脉通路装置、396,951个导管日。
  • 中心静脉通路装置失败率为5%(95%CI 3-6%),血液透析导管的失败率和比例最高。
  • 总体中心线相关血流感染率为4.59/1000导管日(95%CI 2.31-6.86),非隧道式中心静脉通路装置发生率最高。
  • 因疑似感染拔除中心静脉通路装置的比例为17%(20.4/1000导管日,95%CI 15.7-25.2)。
  • 次要结局包括中心线相关血流感染、导管相关血流感染、导管相关血栓、闭塞、因疑似感染拔管、脱位、断裂和局部感染。

证据类型、等级与局限

  • 证据类型:系统评价,纳入观察性(前瞻性和回顾性)或干预性设计研究。
  • 由两名评价者独立筛选文献、评估合格性、提取数据并评估偏倚风险。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为中心静脉通路装置并发症和装置失败是成人ICU中普遍且重要的问题,导致显著的患者伤害和医疗费用增加。
  • 作者认为因疑似感染拔管比例高而总体中心线相关血流感染和导管相关血流感染率低,提示需要稳健的实践指南来指导疑似感染中心静脉通路装置的拔除决策。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To examine the proportion and rate of central venous access device failure and complications across central venous access device types in adult intensive care.

DATA SOURCES: A systematic search was undertaken in the electronic databases Cochrane Central Register of Controlled Trials, Embase, U.S. National Library of Medicine National Institutes of Health, and Cumulative Index to Nursing and Allied Health in September 2017.

STUDY SELECTION: Included studies were of observational (prospective and retrospective) or interventional design and reported central venous access device failure and complications in adult ICU settings. Studies were excluded if they were published prior to November 2006 or not reported in English. Two reviewers independently screened articles, assessed eligibility, extracted data, and assessed risk of bias.

DATA EXTRACTION: Data were extracted on the primary outcome, central venous access device failure, and secondary outcomes: central venous access device complications (central line-associated bloodstream infection, catheter-related bloodstream infection, catheter-related thrombosis, occlusion, catheter removal due to suspected infection, dislodgement, breakage, and local infection). Patient and device data and study details to assess the study quality were also extracted.

DATA SYNTHESIS: A total of 63 studies involving 50,000 central venous access devices (396,951 catheter days) were included. Central venous access device failure was 5% (95% CI, 3-6%), with the highest rates and proportion of failure in hemodialysis catheters. Overall central line-associated bloodstream infection rate was 4.59 per 1,000 catheter days (95% CI, 2.31-6.86), with the highest rate in nontunneled central venous access devices. Removal of central venous access device due to suspected infection was high (17%; 20.4 per 1,000 catheter days; 95% CI, 15.7-25.2).

CONCLUSIONS: Central venous access device complications and device failure is a prevalent and significant problem in the adult ICU, leading to substantial patient harm and increased healthcare costs. The high proportion of central venous access devices removed due to suspicion of infection, despite low overall central line-associated bloodstream infection and catheter-related bloodstream infection rates, indicates a need for robust practice guidelines to inform decision-making surrounding removal of central venous access devices suspected of infection.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Takashima M, Schults J, Mihala G, et al. Complication and Failures of Central Vascular Access Device in Adult Critical Care Settings. Crit Care Med. 2018. PMID: 30095499. doi:10.1097/CCM.0000000000003370

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。